Introduction
When sourcing pharmaceutical APIs, one of the most common questions buyers ask is: "Which pharmacopoeial standard should I specify — BP, USP, or EP?" The answer depends on your target market, regulatory requirements, and the specific API you're sourcing. This guide provides a clear, practical comparison to help you make the right choice.
What is a Pharmacopoeia? A pharmacopoeia is an official publication containing standards for drug substances, excipients, and dosage forms. It defines quality specifications including identity tests, purity requirements, assay methods, and acceptable impurity limits.
The Three Major Pharmacopoeias
🇺🇸 USP
United States Pharmacopeia
Published by: USP Convention
Primary market: USA, Americas
Updated: Continuously online
🇬🇧 BP
British Pharmacopoeia
Published by: MHRA (UK)
Primary market: UK, Commonwealth
Updated: Annually
🇪🇺 EP
European Pharmacopoeia
Published by: EDQM
Primary market: 42 European countries
Updated: Biennial + supplements
Detailed Comparison
| Aspect | USP | BP | EP |
|---|---|---|---|
| Geographic scope | USA, Latin America, parts of Asia | UK, Commonwealth nations, Africa | EU member states (42 countries) |
| Legal binding | Legally enforceable in USA (FDA) | Legally enforceable in UK | Legally enforceable in EU |
| Relationship | Independent standard | Adopts EP monographs where available | Source for BP where applicable |
| Number of monographs | ~5,000+ | ~3,000+ | ~2,300+ |
| Testing methods | HPLC, GC, titration, etc. | Similar to EP | Harmonized EU methods |
| General chapters | Extensive (<1>, <2>...) | Appendix-based | Numbered sections (2.1, 2.2...) |
| Impurity limits | Often stricter than EP | Generally aligned with EP | Risk-based ICH-harmonized |
| Certificate of Suitability | USP Reference Standard | BP Reference Substance | CEP (EDQM) |
Which Standard for Which Market?
| Target Market | Required Standard | Notes |
|---|---|---|
| USA (FDA regulated) | USP | USP-NF required for FDA-registered drugs |
| European Union | EP (via CEP or dossier) | BP also accepted; EP preferred |
| United Kingdom (post-Brexit) | BP (or EP) | MHRA may accept EP monographs |
| Africa (most countries) | BP or WHO | British colonial influence; WHO for NAFDAC, etc. |
| India | IP (Indian Pharmacopoeia) | IP often harmonized with BP/USP |
| China domestic | ChP (Chinese Pharmacopoeia) | Export products often need USP/EP/BP |
| Middle East / GCC | BP or USP | Varies by country; BP common in former British territories |
| Southeast Asia | BP or USP | Depends on regulatory authority of each country |
| WHO PQ programs | USP, EP, or BP | Any of the three major pharmacopoeias accepted |
Practical Recommendations
- For multi-market supply: Request "EP/USP/BP" compliant API — most reputable Chinese manufacturers can provide all three COAs
- For US market focus: Specify USP grade and request USP Reference Standard testing
- For African markets: BP is generally sufficient and most widely recognized
- For EU registration: EP with CEP is the gold standard; reduces regulatory burden significantly
Good News: For most common APIs (antibiotics, vitamins, etc.), the specifications in USP, BP, and EP are very similar — primarily the same purity requirements and similar test methods. A high-quality API from a reputable Chinese GMP manufacturer will typically meet all three standards simultaneously.
Request USP / BP / EP Grade APIs
We provide APIs with multiple pharmacopoeial COAs — specify your target market and we'll provide matching documentation